Skip to main content
SpringerLink
Log in

Estimating the cost of BREs in ITP in the US

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. The study was sponsored by Amgen Inc.

Reference

  • Lin J, et al. Cost of Bleeding-related Episodes in Adult Patients With Primary Immune Thrombocytopenia: A Population-based Retrospective Cohort Study of Administrative Claims Data for Commercial Payers in the United States. Clinical Therapeutics : 9 Feb 2017. Available from: URL: http://doi.org/10.1016/j.clinthera.2017.01.023

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Estimating the cost of BREs in ITP in the US. PharmacoEcon Outcomes News 772, 17 (2017). https://doi.org/10.1007/s40274-017-3765-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-3765-6

Search

Navigation